WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to mifepristone, a medication used to end early pregnancies. The decision is the first of its kind and could affect how other states handle access to drugs that are approved by the U.S. Food and Drug Administration (FDA).

A federal appeals court has upheld a lower court’s decision to restrict abortion pill sales in West Virginia. A three-judge panel of the 4th U.S.

West Virginia can block access to the abortion-inducing drug mifepristone, a federal appeals court said Tuesday in a landmark decision testing the reach of states’ power to restrict the medication despite its FDA approval.